Taking one step beyond previous studies that evaluated short-term antidepressant treatment responses (up to 12 weeks) [10, 13, 14], we demonstrated the role of higher TNF-α levels as a biomarker for 12-month non-remission and 24-month relapse in patients with depressive disorders. This evidence concerns the gene TNF and depressive disorder.